Skip to content

PREVOR

Active Private limited companyfounded 2015active for 11 yearsRue des Chasseurs-Ardennais 3, 4031 LiègeKBO/BCE: BE 0632.637.067 subsidiary of #10 company by total assets in the province of Liège, Pharmaceuticals sector

Lifetime

10 annual accounts with figures on one time axis
peak of €3.9m in 2025
€3.9m▲ 1.6%
peak of €288,592 in 2025
€288,592▲ 8.8%
peak of €1.4m in 2025
€1.4m▲ 27.1%
€2.4m▼ 9.2%
peak of 19 FTE in 2025
19 FTE▲ 22.6%
Board2 names since 2015
1 director
Owners
100%
Documentsfilings and deeds
28-04-202659 days late
2025financial year
Staff from 15.5 FTE to 19 FTEEquity from €1.1m to €1.4m

Key points

from the 2025 annual accounts

Overdue debts

€9,737 on 31-07-2025

The annual accounts state €9,737 of overdue social security (RSZ) debts on 31-07-2025.

Equity

€1.4m ▲ 27.1%

PREVOR has made a profit in every financial year since 2016.

Growth

8 years
2019202020212022202320242025

8 years of growth in a row. Turnover of €3.9m in 2025.

Investments

€70,219 0.3 times depreciation
2022202320242025

Green is investment, beige is depreciation.

Staff

20 employees on 31-07-2025
2220225220231042024512025

In 2025, 5 employees joined and 1 left.

Filings

10 annual accounts 7 late
deadline20202025

The 2017 accounts came in latest, 715 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as PREVOR has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,816 companies, not a prediction for PREVOR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 22-06-2015
Director
  • 100%annual accounts 31-07-2025

Shares in 1 company,

Board & ownership

Recent changes

reappointed as director appointed as director · General meeting of 28-10-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0632637067
Resignations & appointments Director discharge: · General meeting of 16-12-2022 · Gazette deed
Director discharge: General meeting of 17-12-2021 · Gazette deed
All 24 events

Comparable companies

same main activity, similar in size and age
Company
PREVOR Liège €3.9m 11.4% 36.1% 19
Curium PET Liège Liège €2.8m -22.9% -145.4% 12.2
THYMOLUX Marche-en-Famenne €6.4m 32.3% 75.4% 23.9
Sartorius Xpress Biologics Herstal €2.4m - -86.9% 76.2
Perseus Biomics Leuven - - 39.2% 14.3
MY®HEALTH Lummen - - 23.9% 12.2
ATB THERAPEUTICS Marche-en-Famenne - - 47.8% 17
-10%0%10%20%€50,000€500,000€5m€50m€500m€5bnPREVOREBIT margin

Grey: the largest companies of the sector (pharmaceuticals (NACE 21)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as PREVOR: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21100). They are comparable in size and age: total assets between €1.9m and €11m, founded between 2007 and 2017.

Official details

Source: KBO
Status
Active since 22-06-2015Normal situation
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21100and 2 others
Joint committee
207White-collar workers in the chemical industry · annual accounts 31-07-2025
Establishment unit
2.244.451.1284031 Liège, since 22-06-2015
Financial year end
31 July
Peppol
Reachable since 15-12-2025
Company details

Annual accounts to 31-07-2025

€3.7m▲ 1.2%
Employeeson 31-07-2025
20▲ 25.0%
Filing
Filed on 28-04-2026
Financials

Insights on PREVOR

PREVOR has existed since 2015. In 2018 turnover rose from €325,895 to €852,971 and staff from 2.2 to 5.3 full-time equivalents.

Turnover has grown every year since. Solvency rose in 2025 from 28.8% to 36.1% because of the retained profit.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PREVOR

What is the company number of PREVOR?
The company number of PREVOR is 0632.637.067. The VAT number is the same number with BE in front: BE 0632.637.067.
Where is PREVOR based?
The registered office is at Rue des Chasseurs-Ardennais 3, 4031 Liège.Company details
What does PREVOR do?
According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21100).
What is the legal form of PREVOR?
PREVOR is a private limited company (BV).
When was PREVOR founded?
PREVOR was founded on 22-06-2015.
Is PREVOR still active?
Yes, PREVOR is an active enterprise in the KBO register.
How many employees does PREVOR have?
PREVOR had an average of 19 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PREVOR fall under?
In its 31-07-2025 annual accounts, PREVOR states joint committee 207 (White-collar workers in the chemical industry).
What is the turnover of PREVOR?
The turnover of PREVOR was €3.9m in financial year 2025, according to the filed annual accounts.
Is PREVOR profitable?
In financial year 2025, PREVOR made a profit of €288,592.
Where can I find the annual accounts of PREVOR?
PREVOR filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PREVOR due?
PREVOR must file the annual accounts for financial year 2026 by 28-02-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.